Gamelin Erick
Insider CIK 1950551 · ACRV Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 400 | $2.01 | $804 | 52,592 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 400 | $2.01 | $804 | 52,592 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2026-05-18 | 2026-05-20 | 38,584 | — | $0 | 52,992 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2026-05-14 | 2026-05-18 | 404 | $1.92 | $776 | 14,408 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2026-03-01 | 2026-03-03 | 94,946 | — | $0 | 94,946 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2026-02-14 | 2026-02-18 | 471 | $1.63 | $768 | 14,812 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-11-14 | 2025-11-18 | 403 | $2.24 | $903 | 15,283 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-08-14 | 2025-08-18 | 403 | $1.39 | $560 | 15,686 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-05-14 | 2025-05-16 | 403 | $1.14 | $459 | 16,089 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2025-03-01 | 2025-03-04 | 78,078 | — | $0 | 78,078 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-02-14 | 2025-02-19 | 469 | $5.42 | $2.5K | 16,492 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-11-14 | 2024-11-18 | 402 | $7.92 | $3.2K | 16,961 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-08-14 | 2024-08-16 | 402 | $7.02 | $2.8K | 17,363 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-05-14 | 2024-05-16 | 402 | $8.36 | $3.4K | 17,765 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-11-27 | 45,045 | — | $0 | 45,045 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-02-14 | 2024-02-16 | 468 | $3.40 | $1.6K | 18,167 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2023-11-14 | 2023-11-16 | 1,395 | $5.08 | $7.1K | 18,635 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2022-11-14 | 2022-11-16 | 60,090 | — | $0 | 60,090 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2022-11-14 | 2022-11-16 | 20,030 | — | $0 | 20,030 | SEC↗ |